SensUs

Sensus Healthcare Fourth Quarter 2022 Financial Results Include Quarterly Revenues of $13.1 Million

Retrieved on: 
Thursday, February 9, 2023

BOCA RATON, Fla., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions (Company or Sensus), announces financial results for the three and 12 months ended December 31, 2022.

Key Points: 
  • Cost of sales for the fourth quarter of 2022 was $4.8 million, compared with $4.2 million for the prior-year quarter.
  • Gross profit for the fourth quarter of 2022 was $8.4 million, or 63.7% of revenues, compared with $8.9 million, or 68.0% of revenues, for the fourth quarter of 2021.
  • Selling and marketing expense for the fourth quarter of 2022 was $1.6 million, compared with $1.3 million for the fourth quarter of 2021.
  • Adjusted EBITDA for the fourth quarter of 2022 was $4.3 million, compared with $5.6 million for the fourth quarter of 2021.

Global Smart Water Metering Markets, 2022-2027 with Badger Meter, Sensus, Aclara Technologies, Itron, and Diehl Stiftung Dominating - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 18, 2023

Such factors are driving the need for improving water metering infrastructure to reduce heavy water losses.

Key Points: 
  • Such factors are driving the need for improving water metering infrastructure to reduce heavy water losses.
  • The smart water metering market has been segmented into ultrasonic meters, electromagnetic meters, and smart mechanical meters based on meter type.
  • These factors are driving the growth of the electromagnetic smart water metering market.
  • Based on the component, the smart water metering market has been split into meters and accessories, IT solutions, and communications.

Sensus Healthcare Announces Senior Management Appointments and Promotions

Retrieved on: 
Monday, January 9, 2023

BOCA RATON, Fla, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce the following promotions and appointments to its management team:

Key Points: 
  • BOCA RATON, Fla, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce the following promotions and appointments to its management team:
    Ms. Martinez joined Sensus nine years ago and subsequently held positions of increasing responsibility.
  • Mr. Sosa joined Sensus last year as Vice President of Technology Development with extensive experience in banking, cyber security and artificial intelligence.
  • I am delighted to announce these promotions and appointments and look forward to the contributions of these talented individuals as Sensus executes on an aggressive business strategy,” said Joe Sardano, chairman and chief executive officer of Sensus Healthcare.
  • “Our goal is for Sensus to be a destination for great employees from all walks of life and backgrounds.

Sensus Healthcare Announces Preliminary Fourth Quarter 2022 Revenues

Retrieved on: 
Thursday, January 5, 2023

BOCA RATON, Fla, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today reports preliminary 2022 fourth quarter and full year revenues.

Key Points: 
  • Fourth quarter revenues to exceed $13 million; full year revenues to exceed $44 million, representing growth of 60%
    BOCA RATON, Fla, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today reports preliminary 2022 fourth quarter and full year revenues.
  • Fourth quarter 2022 revenues are expected to include more than $500,000 from the company’s aesthetics business.
  • Sensus also announces it expects that both the fourth quarter and the full year will be profitable.
  • Sensus Healthcare plans to announce 2022 fourth quarter and full year financial results and hold an investment community conference call after the close of the U.S. stock markets on February 9, 2023.

K&N Reaches Agreement with 100% of Lenders and Equity Sponsor to Recapitalize its Balance Sheet and Position K&N for Future Success

Retrieved on: 
Tuesday, January 3, 2023

RIVERSIDE, Calif., Jan. 3, 2023 /PRNewswire/ -- K&N Engineering, Inc. ("K&N" or the "Company") today announced that it has taken steps to strengthen its financial foundation and position the business for continued long-term success.

Key Points: 
  • The Company has entered into a Restructuring Support Agreement ("RSA") with 100% of its lenders to significantly strengthen its financial position.
  • K&N remains committed to its strong vendor relationships and talented team members, which underpin the Company's success and market leadership position.
  • K&N today also announced that it has appointed Randy Bays as interim Chief Executive Officer, effective January 3, 2023.
  • Mr. Bays succeeds Richard Bisson, who is stepping down as the Company's CEO to manage his family office.

Smart Water Metering Market Worth $6.4 Billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, December 12, 2022

The water utilities segment accounts for the largest share of the global Smart Water Metering Market.

Key Points: 
  • The water utilities segment accounts for the largest share of the global Smart Water Metering Market.
  • AMR is anticipated to be the fastest-growing smart water metering segment, by technology, during the forecast period.
  • In this report, the Smart Water Metering Market has been analyzed for five regions, namely, Asia Pacific, North America, Europe, Middle East & Africa, and South America.
  • On the other hand, underdeveloped countries still lack basic water infrastructure, which is hampering the growth of the Asia Pacific Smart Water Metering Market.

Smart Water Metering Market Worth $6.4 Billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, December 12, 2022

The water utilities segment accounts for the largest share of the global Smart Water Metering Market.

Key Points: 
  • The water utilities segment accounts for the largest share of the global Smart Water Metering Market.
  • AMR is anticipated to be the fastest-growing smart water metering segment, by technology, during the forecast period.
  • In this report, the Smart Water Metering Market has been analyzed for five regions, namely, Asia Pacific, North America, Europe, Middle East & Africa, and South America.
  • On the other hand, underdeveloped countries still lack basic water infrastructure, which is hampering the growth of the Asia Pacific Smart Water Metering Market.

Xylem Honors Texas, Michigan Water Utilities for Making Communities More Resilient

Retrieved on: 
Thursday, November 10, 2022

The Reach Transformation award goes to Fort Worths Deputy Water Director Kara Shuror and Aqua-Metric Project Manager Paul Morrison.

Key Points: 
  • The Reach Transformation award goes to Fort Worths Deputy Water Director Kara Shuror and Aqua-Metric Project Manager Paul Morrison.
  • The Reach Transformation Award honors those who reach farther through the application of Xylem technology to make operational advancements, improve customer service and optimize data.
  • The Xylem Reachconference brings industry leaders together to discuss smart sustainable solutions for water, gas and electric utilities.
  • Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation.

Green Technology and Sustainability Market Worth $ 60.7 Billion By 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, November 3, 2022

Hence, the rise in the understanding of technology causing environmental hazards is a major factor that drives the adoption of green technology and sustainability solution among verticals across the globe, which, in turn, drives the green technology and sustainability market growth.

Key Points: 
  • Hence, the rise in the understanding of technology causing environmental hazards is a major factor that drives the adoption of green technology and sustainability solution among verticals across the globe, which, in turn, drives the green technology and sustainability market growth.
  • The green technology and sustainability market by technology has been segmented into IoT, AI and analytics, digital twin, cloud computing, security, and blockchain.
  • The green technology and sustainability market has been segmented into five regions: North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
  • These companies are continuously innovating to enhance their green technology and sustainability capabilities for better efficiency and reliability, thereby paving the way for the global green technology and sustainability market to emerge as a mainstream technology.

Sensus Healthcare to Host Third Quarter 2022 Financial Results and Business Update Conference Call on November 3, 2022

Retrieved on: 
Thursday, October 27, 2022

In addition, management will provide a business update and a discussion on recent and upcoming milestones.

Key Points: 
  • In addition, management will provide a business update and a discussion on recent and upcoming milestones.
  • To access the conference call, the dial-in numbers are 866-777-2509 (U.S. and Canada Toll Free), 412-317-5413 (International).
  • Please direct the operator to be connected to the Sensus Healthcare conference call.
  • Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions.